The UK's National Health Service just approved a drug that costs nearly $2.5 million a dose
March 08, 2021 at 09:33 AM EST
The innovative gene therapy called "Zolgensma" does not come cheap, with a reported list price of £1.79 million ($2.48 million) per dose.
